Insulin resistance in pre-school very-low-birth weight pre-term children

S Bo1, E Bertino, R Bagna

  • 1Department of Internal Medicine, University of Turin, Italy. sbo@molinette.piemonte.it

Insights

Rapid weight gain in early childhood in preterm very-low-birthweight (VLBW) children is linked to metabolic issues, regardless of gestational age. This growth pattern predicts higher insulin and insulin resistance in pre-schoolers.

Area of Science:

  • Pediatric Endocrinology
  • Neonatology
  • Metabolic Health

Background:

  • Preterm very-low-birthweight (VLBW) infants face long-term health challenges.
  • Understanding metabolic patterns in VLBW survivors is crucial for preventative care.

Purpose of the Study:

  • To assess metabolic profiles of pre-school small-for-gestational age (SGA) and appropriate-for-gestational age (AGA) VLBW children.
  • To determine if early-life growth rate influences later metabolic and anthropometric characteristics.

Main Methods:

  • Evaluated 58 VLBW Italian children (16 SGA, 42 AGA) at pre-school age (>2 to <6 years corrected).
  • Assessed anthropometric, clinical, and laboratory (34 children) parameters.
  • Analyzed weight centile crossing (CC) and its association with metabolic markers.

Main Results:

  • SGA and AGA children showed similar pre-school characteristics.
  • A significant weight centile crossing (CC) was observed in 69% of SGA and 51% of AGA children by 24 months.
  • Higher fasting glucose, insulin, and HOMA-IR were noted in children with CC.
  • Weight gain from birth to 24 months strongly predicted pre-school BMI, waist circumference, insulin, and HOMA-IR.

Conclusions:

  • Adverse metabolic patterns in pre-school VLBW children are associated with postnatal rapid weight gain.
  • This association is independent of whether the child was small- or appropriate-for-gestational age at birth.
Abstract

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...